Adalimumab treatment of anti-TNF-naive patients with ulcerative colitis: Deep remission and response factors

Munoz-Villafranca, C; de Zarate, JO; Arreba, P; Higuera, R; Gomez, L; Ibanez, S; Merino, O; Munagorri, A; Ogueta, M; Rodriguez, C; Nantes, O; de la Piscina, PR; Rodriguez, I; Bernal, A; Arevalo, J; Cabriada, J

Munoz-Villafranca, C (reprint author), Univ Hosp Basurto, Dept Gastroenterol, Avda Montevideo 18, Bilbao 48013, Vizcaya, Spain.

DIGESTIVE AND LIVER DISEASE, 2018; 50 (8): 812

Abstract

Background: Adalimumab is the second tumour necrosis factor antagonist (anti-TNF) adopted for the treatment of ulcerative colitis. Clinical data from ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索